Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic

  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Stereotaxis Inc (NY: STXS )

2.135 +0.045 (+2.15%)
Streaming Delayed Price Updated: 11:14 AM EDT, May 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 93,464
Open 2.100
Bid (Size) 2.130 (8)
Ask (Size) 2.140 (8)
Prev. Close 2.090
Today's Range 2.100 - 2.150
52wk Range 1.330 - 3.290
Shares Outstanding 82,128,762
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
STXS Stock Earnings: Stereotaxis Meets EPS, Misses Revenue for Q1 2024
STXS stock results show that Stereotaxis met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
3 Penny Stocks That Could Make a Big Comeback by the End of Q2
Although penny stocks to rebound represent one of the riskiest market categories, there could be some substance here. 
Via InvestorPlace

Performance

YTD
+14.17%
+14.17%
1 Month
-20.93%
-20.93%
3 Month
-19.43%
-19.43%
6 Month
+50.35%
+50.35%
1 Year
+5.69%
+5.69%

More News

Read More
7 Penny Stocks That Could 5X by the End of 2024
Via InvestorPlace
Low-Priced, High-Potential: 7 Cheap Stocks Under $10 to Try Your Luck With
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Recap: Stereotaxis Q4 Earnings
Via Benzinga
Earnings Preview For Stereotaxis
Via Benzinga
Recap: Stereotaxis Q3 Earnings
Via Benzinga
A Preview Of Stereotaxis's Earnings
Via Benzinga
Earnings Scheduled For March 4, 2024
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Insiders Buying Eyenovia And 3 Other Stocks Under $2
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Stereotaxis's Earnings: A Preview
Via Benzinga
Stereotaxis And 3 Other Stocks Under $2 Insiders Are Aggressively Buying
Via Benzinga
Topics Stocks
Exposures US Equities
Stereotaxis Clocks 28% Revenue Growth In Q2 On Continued Demand For Robotic Technology
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
US Stocks Mixed; Dow Gains 50 Points
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Crude Oil Down 1%; Foot Locker Earnings Miss Expectations
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Stereotaxis, Abbott Ink Pact To Combine Mapping & Robotic Tech: FDA Approves Abbott's Next-Gen Abalation Catheter
Via Benzinga
Why Foot Locker Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
US Stocks Turn Lower; Dow Dips Over 100 Points
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.